Medicines Substances Companies Statistics

A free, open platform for EU medicines data, based on official EMA data.

Database

Medicines
Substances
Companies

Data Sources

EMA

2026 uMedical - Open Source Project

Imprint
Privacy Policy
Terms
Contact

Doxolipad

RefusedHuman

Details

EMA number	EMEA/H/C/004110
ATC code	L01DB01
Authorisation	-
Revision	-

Therapeutic indication

Treatment of breast and ovarian cancer.

MeSH: Breast Neoplasms;Ovarian Neoplasms

Group: Antineoplastic agents

Active substances

doxorubicin hydrochloride

Marketing Authorisation Holder

TLC Biopharmaceuticals B.V.

Doxolipad | uMedical